首页> 外文OA文献 >Prostate-specific antigen and (free prostate-specific antigen/ prostate-specific antigen) ratio in patients with Benign Prostatic Hyperplasia and Prostate Cancer

【2h】

Prostate-specific antigen and (free prostate-specific antigen/ prostate-specific antigen) ratio in patients with Benign Prostatic Hyperplasia and Prostate Cancer

机译：良性前列腺增生和前列腺癌患者的前列腺特异性抗原和（自由前列腺特异性抗原/前列腺特异性抗原）比例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Amal A. Hussein; Rayah S. Baban; Alaa G. Hussein;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Gap Between Total Prostate-specific Antigen and the Sum of Free Prostate-specific Antigen Plus α1-Antichymotrypsin-Prostate-specific Antigen in Patients with Prostate Carcinoma but not in Those with Benign Prostate Hyperplasia [J] . Angela Kn?bich, Brigitte Brux, Dietmar Schnorr, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 1999,第3期

机译：前列腺癌患者总前列腺特异性抗原与游离前列腺特异性抗原加α1-抗胰凝乳蛋白酶-前列腺特异性抗原之和之间的差距，但与前列腺增生患者不同
2. Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml [J] . Shingo Yamamoto, Takuo Maruyama, Nobuyuki Kondoh, International Urology and Nephrology . 2008,第1期

机译：游离或总前列腺特异性抗原比率与前列腺特异性抗原速度的总和对单独检测和联合检测总血清前列腺特异性抗原在4至10 ng / ml之间的患者的诊断功效
3. Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml. [J] . Yamamoto S, Maruyama T, Kondoh N, International Urology and Nephrology . 2008,第1期

机译：游离或总前列腺特异性抗原比率与前列腺特异性抗原速度之比单独或组合用于检测血清总前列腺特异性抗原在4至10 ng / ml之间的患者的前列腺癌。
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia [O] . Tae Yong Park, Ji Yun Chae, Jong Wook Kim, 2013

机译：前列腺特异性抗原质量和游离前列腺特异性抗原质量用于预测经活检证实为良性前列腺增生的韩国男性的前列腺体积
7. Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01–10.0 ng/ml) [O] . Selahattin Çaliskan 2017

机译：游离前列腺特异性抗原/总前列腺特异性抗原比率诊断前列腺癌的低浓度（≤4ng/ ml）和中等水平的前列腺特异性抗原（4.01-10.0 ng / ml）的诊断效果

Prostate-specific antigen and (free prostate-specific antigen/ prostate-specific antigen) ratio in patients with Benign Prostatic Hyperplasia and Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅